Intense Cholesterol Lowering Therapy with a HMG-CoA Reductase Inhibitor does not Improve Nitric Oxide Dependent Endothelial Function in Type-2-Diabetes - Balletshofer, B M; Goebbel, S; Rittig, K; Enderle, M; Schmölzer, I; Wascher, T C; Ferenc Pap, A; Westermeier, T; Petzinna, D; Matthaei, S; Häring, H U (Experimental and Clinical Endocrinology & Diabetes, 2005)